nature.com search

Loading Filters

Showing 1–50 of 67 results

Loading Filters

Amendments and Corrections | 9 April 2014
Erratum: Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma
- R A Kyle
- & S V Rajkumar
Leukemia 28 , 980–980

Rights & permissionsfor article Erratum: Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma . Opens in a new window.
Amendments and Corrections | 13 February 2015
Erratum: Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study
- A J Greenberg
- , S Philip
- , A Paner
- , S Velinova
- , A Badros
- , R Catchatourian
- , R Ketterling
- , R A Kyle
- , S Kumar
- , C M Vachon
- & S V Rajkumar
Blood Cancer Journal 5 , e279–e279

Rights & permissionsfor article Erratum: Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study . Opens in a new window.
Amendments and Corrections | 13 August 2008
Erratum: The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement
- M A Hussein
- , F D Vrionis
- , R Allison
- , J Berenson
- , S Berven
- , E Erdem
- , S Giralt
- , S Jagannath
- , R A Kyle
- , S LeGrand
- , R Pflugmacher
- , N Raje
- , S V Rajkumar
- , R L Randall
- , D Roodman
- , D Siegel
- , R Vescio
- , J Zonder
- & B G M Durie
Leukemia 22 , 1649–1649

Rights & permissionsfor article Erratum: The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement . Opens in a new window.
Research | 27 June 2020
N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression
- Angela Dispenzieri
- , D. R. Larson
- , S. V. Rajkumar
- , R. A. Kyle
- , S. K. Kumar
- , Taxiarchis Kourelis
- , Bonnie Arendt
- , Maria Willrcih
- , Surendra Dasari
- & David Murray
Leukemia 34 , 2749–2753

Rights & permissionsfor article N-glycosylation of monoclonal light chains on routine MASS-FIX testing is a risk factor for MGUS progression . Opens in a new window.
Research | 11 July 2012
Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS
- J A Katzmann
- , R Clark
- , R A Kyle
- , D R Larson
- , T M Therneau
- , L J Melton III
- , J T Benson
- , C L Colby
- , A Dispenzieri
- , O Landgren
- , S Kumar
- , A R Bradwell
- , J R Cerhan
- & S V Rajkumar
Leukemia 27 , 208–212

Rights & permissionsfor article Suppression of uninvolved immunoglobulins defined by heavy/light chain pair suppression is a risk factor for progression of MGUS . Opens in a new window.
11 April 2016
Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy
- W I Gonsalves
- , S V Rajkumar
- , M A Gertz
- , A Dispenzieri
- , M Q Lacy
- , F K Buadi
- , D Dingli
- , R S Go
- , N Leung
- , P Kapoor
- , S R Hayman
- , J A Lust
- , S J Russell
- , S R Zeldenrust
- , Y L Hwa
- , T V Kourelis
- , R A Kyle
- & S K Kumar
Bone Marrow Transplantation 51 , 1156–1158

Rights & permissionsfor article Clinical course and outcomes of patients with multiple myeloma who relapse after autologous stem cell therapy . Opens in a new window.
21 October 2016 | Open
Prevalence, incidence and survival of smoldering multiple myeloma in the United States
- A Ravindran
- , A C Bartley
- , S J Holton
- , W I Gonsalves
- , P Kapoor
- , M A Siddiqui
- , S K Hashmi
- , A L Marshall
- , A A Ashrani
- , A Dispenzieri
- , R A Kyle
- , S V Rajkumar
- & R S Go
Blood Cancer Journal 6 , e486–e486

Rights & permissionsfor article Prevalence, incidence and survival of smoldering multiple myeloma in the United States . Opens in a new window.
22 October 2013
Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma
- T V Kourelis
- , S K Kumar
- , G Srivastava
- , M A Gertz
- , M Q Lacy
- , F K Buadi
- , R A Kyle
- & A Dispenzieri
Leukemia 28 , 455–457

Rights & permissionsfor article Long-term response to lenalidomide in patients with newly diagnosed multiple myeloma . Opens in a new window.
Research | 5 February 2013
Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients
- L E Roeker
- , D R Larson
- , R A Kyle
- , S Kumar
- , A Dispenzieri
- & S V Rajkumar
Leukemia 27 , 1391–1393

Rights & permissionsfor article Risk of acute leukemia and myelodysplastic syndromes in patients with monoclonal gammopathy of undetermined significance (MGUS): a population-based study of 17 315 patients . Opens in a new window.
31 March 2005
Five decades of therapy for multiple myeloma: a paradigm for therapeutic models
- R A Kyle
Leukemia 19 , 910–912

Rights & permissionsfor article Five decades of therapy for multiple myeloma: a paradigm for therapeutic models . Opens in a new window.
Research | 3 June 2010
Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma
- S Kumar
- , L Zhang
- , A Dispenzieri
- , S Van Wier
- , J A Katzmann
- , M Snyder
- , E Blood
- , R DeGoey
- , K Henderson
- , R A Kyle
- , A R Bradwell
- , P R Greipp
- , S V Rajkumar
- & R Fonseca
Leukemia 24 , 1498–1505

Rights & permissionsfor article Relationship between elevated immunoglobulin free light chain and the presence of IgH translocations in multiple myeloma . Opens in a new window.
5 September 2012
Treatment patterns and outcomes in elderly patients with multiple myeloma
- S-M Bang
- , R A Kyle
- , S V Rajkumar
- & S Kumar
Leukemia 27 , 971–974

Rights & permissionsfor article Treatment patterns and outcomes in elderly patients with multiple myeloma . Opens in a new window.
5 April 2011
Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma
- P Kapoor
- , S Kumar
- , S J Mandrekar
- , K M Laumann
- , A Dispenzieri
- , M Q Lacy
- , D Dingli
- , M A Gertz
- , R A Kyle
- , P R Greipp
- , S V Rajkumar
- & T E Witzig
Leukemia 25 , 1195–1197

Rights & permissionsfor article Efficacy of thalidomide- or lenalidomide-based therapy in proliferative multiple myeloma . Opens in a new window.
16 August 2012
Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma
- A J Greenberg
- , A M Lee
- , D J Serie
- , S K McDonnell
- , J R Cerhan
- , M Liebow
- , D R Larson
- , C L Colby
- , A D Norman
- , R A Kyle
- , S Kumar
- , S V Rajkumar
- , R B Diasio
- , S L Slager
- & C M Vachon
Leukemia 27 , 515–516

Rights & permissionsfor article Single-nucleotide polymorphism <i>rs1052501</i> associated with monoclonal gammopathy of undetermined significance and multiple myeloma . Opens in a new window.
25 February 2011
Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma
- K Detweiler Short
- , S V Rajkumar
- , D Larson
- , F Buadi
- , S Hayman
- , A Dispenzieri
- , M Gertz
- , S Kumar
- , J Mikhael
- , V Roy
- , R A Kyle
- & M Q Lacy
Leukemia 25 , 906–908

Rights & permissionsfor article Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma . Opens in a new window.
16 September 2011
Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma
- O Landgren
- , W Ma
- , R A Kyle
- , S V Rajkumar
- , N Korde
- & M Albitar
Leukemia 26 , 844–845

Rights & permissionsfor article Polymorphism of the erythropoietin gene promotor and the development of myelodysplastic syndromes subsequent to multiple myeloma . Opens in a new window.
Amendments and Corrections | 7 September 2011
Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis
- P Kapoor
- , S V Rajkumar
- , A Dispenzieri
- , M A Gertz
- , M Q Lacy
- , D Dingli
- , J R Mikhael
- , V Roy
- , R A Kyle
- , P R Greipp
- , S Kumar
- & S J Mandrekar
Leukemia 25 , 1523–1524

Rights & permissionsfor article Erratum: Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant-ineligible patients with multiple myeloma: a meta-analysis . Opens in a new window.
Research | 1 September 2017
Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial
- S Ailawadhi
- , J R Mikhael
- , B R LaPlant
- , K M Laumann
- , S Kumar
- , V Roy
- , D Dingli
- , P L Bergsagel
- , F K Buadi
- , S V Rajkumar
- , R Fonseca
- , M A Gertz
- , P Kapoor
- , T Sher
- , S R Hayman
- , A K Stewart
- , A Dispenzieri
- , R A Kyle
- , W I Gonsalves
- , C B Reeder
- , Y Lin
- , R S Go
- , N Leung
- , T Kourelis
- , J A Lust
- , S J Russell
- , A A Chanan-Khan
- & M Q Lacy
Leukemia 32 , 719–728

Rights & permissionsfor article Pomalidomide–dexamethasone in refractory multiple myeloma: long-term follow-up of a multi-cohort phase II clinical trial . Opens in a new window.
Research | 1 September 2017 | Open
Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma
- M Binder
- , S V Rajkumar
- , R P Ketterling
- , P T Greipp
- , A Dispenzieri
- , M Q Lacy
- , M A Gertz
- , F K Buadi
- , S R Hayman
- , Y L Hwa
- , S R Zeldenrust
- , J A Lust
- , S J Russell
- , N Leung
- , P Kapoor
- , R S Go
- , W I Gonsalves
- , R A Kyle
- & S K Kumar
Blood Cancer Journal 7 , e600–e600

Rights & permissionsfor article Prognostic implications of abnormalities of chromosome 13 and the presence of multiple cytogenetic high-risk abnormalities in newly diagnosed multiple myeloma . Opens in a new window.
Research | 16 June 2017 | Open
Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma
- P Ravi
- , S Kumar
- , W Gonsalves
- , F Buadi
- , M Q Lacy
- , R S Go
- , A Dispenzieri
- , P Kapoor
- , J A Lust
- , D Dingli
- , Y Lin
- , S J Russell
- , N Leung
- , M A Gertz
- , R A Kyle
- , P L Bergsagel
- & S V Rajkumar
Blood Cancer Journal 7 , e569–e569

Rights & permissionsfor article Changes in uninvolved immunoglobulins during induction therapy for newly diagnosed multiple myeloma . Opens in a new window.
Research | 27 June 2017
Natural history of t(11;14) multiple myeloma
- A Lakshman
- , M Alhaj Moustafa
- , S V Rajkumar
- , A Dispenzieri
- , M A Gertz
- , F K Buadi
- , M Q Lacy
- , D Dingli
- , A L Fonder
- , S R Hayman
- , M A Hobbs
- , W I Gonsalves
- , Y L Hwa
- , P Kapoor
- , N Leung
- , R S Go
- , Y Lin
- , T V Kourelis
- , J A Lust
- , S J Russell
- , S R Zeldenrust
- , R A Kyle
- & S K Kumar
Leukemia 32 , 131–138

Rights & permissionsfor article Natural history of t(11;14) multiple myeloma . Opens in a new window.
Research | 18 September 2017
Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains
- S Sidana
- , N Tandon
- , A Dispenzieri
- , M A Gertz
- , F K Buadi
- , M Q Lacy
- , D Dingli
- , A L Fonder
- , S R Hayman
- , M A Hobbs
- , W I Gonsalves
- , Y L Hwa
- , P Kapoor
- , R A Kyle
- , N Leung
- , R S Go
- , J A Lust
- , S J Russell
- , S R Zeldenrust
- , S V Rajkumar
- & S K Kumar
Leukemia 32 , 729–735

Rights & permissionsfor article Clinical presentation and outcomes in light chain amyloidosis patients with non-evaluable serum free light chains . Opens in a new window.
Research | 20 October 2017 | Open
Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10–49 years old: a population-based study from the National Health and Nutrition Examination Survey
- O Landgren
- , B I Graubard
- , S Kumar
- , R A Kyle
- , J A Katzmann
- , K Murata
- , R Costello
- , A Dispenzieri
- , N Caporaso
- , S Mailankody
- , N Korde
- , M Hultcrantz
- , T M Therneau
- , D R Larson
- , J R Cerhan
- & S V Rajkumar
Blood Cancer Journal 7 , e618–e618

Rights & permissionsfor article Prevalence of myeloma precursor state monoclonal gammopathy of undetermined significance in 12372 individuals 10–49 years old: a population-based study from the National Health and Nutrition Examination Survey . Opens in a new window.
Research | 29 July 2016 | Open
Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma
- P Ravi
- , S Kumar
- , J T Larsen
- , W Gonsalves
- , F Buadi
- , M Q Lacy
- , R Go
- , A Dispenzieri
- , P Kapoor
- , J A Lust
- , D Dingli
- , Y Lin
- , S J Russell
- , N Leung
- , M A Gertz
- , R A Kyle
- , P L Bergsagel
- & S V Rajkumar
Blood Cancer Journal 6 , e454–e454

Rights & permissionsfor article Evolving changes in disease biomarkers and risk of early progression in smoldering multiple myeloma . Opens in a new window.
Research | 16 December 2015
Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment
- T V Kourelis
- , F K Buadi
- , M A Gertz
- , M Q Lacy
- , S K Kumar
- , P Kapoor
- , R S Go
- , J A Lust
- , S R Hayman
- , V Rajkumar
- , S R Zeldenrust
- , S J Russell
- , D Dingli
- , Y Lin
- , N Leung
- , Y L Hwa
- , W Gonsalves
- , R A Kyle
- & A Dispenzieri
Leukemia 30 , 1079–1085

Rights & permissionsfor article Risk factors for and outcomes of patients with POEMS syndrome who experience progression after first-line treatment . Opens in a new window.
Research | 23 May 2016
Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents
- N Majithia
- , S V Rajkumar
- , M Q Lacy
- , F K Buadi
- , A Dispenzieri
- , M A Gertz
- , S R Hayman
- , D Dingli
- , P Kapoor
- , L Hwa
- , J A Lust
- , S J Russell
- , R S Go
- , R A Kyle
- & S K Kumar
Leukemia 30 , 2208–2213

Rights & permissionsfor article Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents . Opens in a new window.
Research | 1 December 2016
Interphase fluorescence in situ hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category
- E Muchtar
- , A Dispenzieri
- , S K Kumar
- , R P Ketterling
- , D Dingli
- , M Q Lacy
- , F K Buadi
- , S R Hayman
- , P Kapoor
- , N Leung
- , R Chakraborty
- , W Gonsalves
- , R Warsame
- , T V Kourelis
- , S Russell
- , J A Lust
- , Y Lin
- , R S Go
- , S Zeldenrust
- , R A Kyle
- , S V Rajkumar
- & M A Gertz
Leukemia 31 , 1562–1569

Rights & permissionsfor article Interphase fluorescence <i>in situ</i> hybridization in untreated AL amyloidosis has an independent prognostic impact by abnormality type and treatment category . Opens in a new window.
Research | 11 March 2016 | Open
Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma
- M Binder
- , S V Rajkumar
- , R P Ketterling
- , A Dispenzieri
- , M Q Lacy
- , M A Gertz
- , F K Buadi
- , S R Hayman
- , Y L Hwa
- , S R Zeldenrust
- , J A Lust
- , S J Russell
- , N Leung
- , P Kapoor
- , R S Go
- , W I Gonsalves
- , R A Kyle
- & S K Kumar
Blood Cancer Journal 6 , e401–e401

Rights & permissionsfor article Occurrence and prognostic significance of cytogenetic evolution in patients with multiple myeloma . Opens in a new window.
Research | 26 July 2016
Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression
- W I Gonsalves
- , S V Rajkumar
- , A Dispenzieri
- , D Dingli
- , M M Timm
- , W G Morice
- , M Q Lacy
- , F K Buadi
- , R S Go
- , N Leung
- , P Kapoor
- , S R Hayman
- , J A Lust
- , S J Russell
- , S R Zeldenrust
- , L Hwa
- , T V Kourelis
- , R A Kyle
- , M A Gertz
- & S K Kumar
Leukemia 31 , 130–135

Rights & permissionsfor article Quantification of circulating clonal plasma cells via multiparametric flow cytometry identifies patients with smoldering multiple myeloma at high risk of progression . Opens in a new window.
Research | 23 May 2016
Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival
- E Muchtar
- , A Dispenzieri
- , S K Kumar
- , F K Buadi
- , M Q Lacy
- , S Zeldenrust
- , S R Hayman
- , N Leung
- , T V Kourelis
- , W Gonsalves
- , R Chakraborty
- , S Russell
- , D Dingli
- , J A Lust
- , Y Lin
- , P Kapoor
- , R Go
- , R A Kyle
- , S V Rajkumar
- & M A Gertz
Leukemia 31 , 92–99

Rights & permissionsfor article Immunoparesis in newly diagnosed AL amyloidosis is a marker for response and survival . Opens in a new window.
Research | 20 January 2014
Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey
- O Landgren
- , B I Graubard
- , J A Katzmann
- , R A Kyle
- , I Ahmadizadeh
- , R Clark
- , S K Kumar
- , A Dispenzieri
- , A J Greenberg
- , T M Therneau
- , L J Melton III
- , N Caporaso
- , N Korde
- , M Roschewski
- , R Costello
- , G M McQuillan
- & S V Rajkumar
Leukemia 28 , 1537–1542

Rights & permissionsfor article Racial disparities in the prevalence of monoclonal gammopathies: a population-based study of 12 482 persons from the National Health and Nutritional Examination Survey . Opens in a new window.
Research | 25 October 2013
Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
- S K Kumar
- , A Dispenzieri
- , M Q Lacy
- , M A Gertz
- , F K Buadi
- , S Pandey
- , P Kapoor
- , D Dingli
- , S R Hayman
- , N Leung
- , J Lust
- , A McCurdy
- , S J Russell
- , S R Zeldenrust
- , R A Kyle
- & S V Rajkumar
Leukemia 28 , 1122–1128

Rights & permissionsfor article Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients . Opens in a new window.
Research | 20 March 2015 | Open
Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma
- W I Gonsalves
- , N Leung
- , S V Rajkumar
- , A Dispenzieri
- , M Q Lacy
- , S R Hayman
- , F K Buadi
- , D Dingli
- , P Kapoor
- , R S Go
- , Y Lin
- , S J Russell
- , J A Lust
- , S Zeldenrust
- , R A Kyle
- , M A Gertz
- & S K Kumar
Blood Cancer Journal 5 , e296–e296

Rights & permissionsfor article Improvement in renal function and its impact on survival in patients with newly diagnosed multiple myeloma . Opens in a new window.
Research | 12 May 2015
Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy
- M Alhaj Moustafa
- , S V Rajkumar
- , A Dispenzieri
- , M A Gertz
- , M Q Lacy
- , F K Buadi
- , Y L Hwa
- , D Dingli
- , P Kapoor
- , S R Hayman
- , J A Lust
- , R A Kyle
- & S K Kumar
Leukemia 29 , 2033–2038

Rights & permissionsfor article Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy . Opens in a new window.
Research | 1 May 2015 | Open
Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death
- R Warsame
- , S K Kumar
- , M A Gertz
- , M Q Lacy
- , F K Buadi
- , S R Hayman
- , N Leung
- , D Dingli
- , J A Lust
- , R P Ketterling
- , Y Lin
- , S Russell
- , L Hwa
- , P Kapoor
- , R S Go
- , S R Zeldenrust
- , R A Kyle
- , S V Rajkumar
- & A Dispenzieri
Blood Cancer Journal 5 , e310–e310

Rights & permissionsfor article Abnormal FISH in patients with immunoglobulin light chain amyloidosis is a risk factor for cardiac involvement and for death . Opens in a new window.
Research | 24 August 2015
Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation
- G L Uy
- , L J Costa
- , P N Hari
- , M-J Zhang
- , J-X Huang
- , K C Anderson
- , C N Bredeson
- , N S Callander
- , R F Cornell
- , M A D Perez
- , A Dispenzieri
- , C O Freytes
- , R P Gale
- , A Garfall
- , M A Gertz
- , J Gibson
- , M Hamadani
- , H M Lazarus
- , M E Kalaycio
- , R T Kamble
- , M A Kharfan-Dabaja
- , A Y Krishnan
- , S K Kumar
- , R A Kyle
- , H J Landau
- , C H Lee
- , A Maiolino
- , D I Marks
- , T M Mark
- , R Munker
- , T Nishihori
- , R F Olsson
- , M Ramanathan
- , T E Rodriguez
- , A A Saad
- , B N Savani
- , G J Schiller
- , H C Schouten
- , J R Schriber
- , E Scott
- , S Seo
- , M Sharma
- , S Ganguly
- , E A Stadtmauer
- , J Tay
- , L B To
- , D H Vesole
- , D T Vogl
- , J L Wagner
- , B Wirk
- , W A Wood
- & A D'Souza
Bone Marrow Transplantation 50 , 1513–1518

Rights & permissionsfor article Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation . Opens in a new window.
Research | 25 November 2013
Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation
- C O Freytes
- , D H Vesole
- , J LeRademacher
- , X Zhong
- , R P Gale
- , R A Kyle
- , D E Reece
- , J Gibson
- , H C Schouten
- , P L McCarthy
- , S Lonial
- , A Y Krishnan
- , A Dispenzieri
- & P N Hari
Bone Marrow Transplantation 49 , 416–421

Rights & permissionsfor article Second transplants for multiple myeloma relapsing after a previous autotransplant—reduced-intensity allogeneic vs autologous transplantation . Opens in a new window.
Research | 21 October 2015
Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma
- G P Kaufman
- , M A Gertz
- , A Dispenzieri
- , M Q Lacy
- , F K Buadi
- , D Dingli
- , S R Hayman
- , P Kapoor
- , J A Lust
- , S Russell
- , R S Go
- , Y L Hwa
- , R A Kyle
- , S V Rajkumar
- & S K Kumar
Leukemia 30 , 633–639

Rights & permissionsfor article Impact of cytogenetic classification on outcomes following early high-dose therapy in multiple myeloma . Opens in a new window.
Research | 13 January 2015 | Open
Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study
- A J Greenberg
- , S Philip
- , A Paner
- , S Velinova
- , A Badros
- , R Catchatourian
- , R Ketterling
- , R A Kyle
- , S Kumar
- , C M Vachon
- & S V Rajkumar
Blood Cancer Journal 5 , e271–e271

Rights & permissionsfor article Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study . Opens in a new window.
Research | 6 August 2009
Genetic polymorphisms of EPHX1, Gsk3β, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma
- B G M Durie
- , B Van Ness
- , C Ramos
- , O Stephens
- , M Haznadar
- , A Hoering
- , J Haessler
- , M S Katz
- , G R Mundy
- , R A Kyle
- , G J Morgan
- , J Crowley
- , B Barlogie
- & J Shaughnessy Jr
Leukemia 23 , 1913–1919

Rights & permissionsfor article Genetic polymorphisms of <i>EPHX1, Gsk3β, TNFSF8</i> and myeloma cell <i>DKK-1</i> expression linked to bone disease in myeloma . Opens in a new window.
Research | 1 November 2011
Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research
- A Mahindra
- , M E Kalaycio
- , J Vela-Ojeda
- , D H Vesole
- , M-J Zhang
- , P Li
- , J R Berenson
- , J M Bird
- , A Dispenzieri
- , J L Gajewski
- , R P Gale
- , L Holmberg
- , S Kumar
- , R A Kyle
- , H M Lazarus
- , S Lonial
- , J Mikhael
- , G A Milone
- , R Munker
- , R Nath
- , S Saccaro
- , L Bik To
- , D T Vogl
- , B Wirk
- & P Hari
Leukemia 26 , 1091–1097

Rights & permissionsfor article Hematopoietic cell transplantation for primary plasma cell leukemia: results from the Center for International Blood and Marrow Transplant Research . Opens in a new window.
Research | 31 May 2004
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy
- S Kumar
- , M A Gertz
- , A Dispenzieri
- , M Q Lacy
- , L A Wellik
- , R Fonseca
- , J A Lust
- , T E Witzig
- , R A Kyle
- , P R Greipp
- & S V Rajkumar
Bone Marrow Transplantation 34 , 235–239

Rights & permissionsfor article Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapy . Opens in a new window.
Research | 26 March 2009
Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant
- P N Hari
- , M-J Zhang
- , V Roy
- , W S Pérez
- , A Bashey
- , L B To
- , G Elfenbein
- , C O Freytes
- , R P Gale
- , J Gibson
- , R A Kyle
- , H M Lazarus
- , P L McCarthy
- , G A Milone
- , S Pavlovsky
- , D E Reece
- , G Schiller
- , J Vela-Ojeda
- , D Weisdorf
- & D Vesole
Leukemia 23 , 1528–1534

Rights & permissionsfor article Is the international staging system superior to the Durie–Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant . Opens in a new window.
Research | 20 August 2012
High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma
- G Bianchi
- , R A Kyle
- , D R Larson
- , T E Witzig
- , S Kumar
- , A Dispenzieri
- , W G Morice
- & S V Rajkumar
Leukemia 27 , 680–685

Rights & permissionsfor article High levels of peripheral blood circulating plasma cells as a specific risk factor for progression of smoldering multiple myeloma . Opens in a new window.
Research | 3 July 2008
Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system
- C L H Snozek
- , J A Katzmann
- , R A Kyle
- , A Dispenzieri
- , D R Larson
- , T M Therneau
- , L J Melton III
- , S Kumar
- , P R Greipp
- , R J Clark
- & S V Rajkumar
Leukemia 22 , 1933–1937

Rights & permissionsfor article Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system . Opens in a new window.
Research | 14 January 2011
Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis
- P Kapoor
- , S V Rajkumar
- , A Dispenzieri
- , M A Gertz
- , M Q Lacy
- , D Dingli
- , J R Mikhael
- , V Roy
- , R A Kyle
- , P R Greipp
- , S Kumar
- & S J Mandrekar
Leukemia 25 , 689–696

Rights & permissionsfor article Melphalan and prednisone versus melphalan, prednisone and thalidomide for elderly and/or transplant ineligible patients with multiple myeloma: a meta-analysis . Opens in a new window.
Research | 1 December 2003
Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age
- D E Reece
- , C Bredeson
- , W S Pérez
- , S Jagannath
- , M J Zhang
- , K K Ballen
- , G J Elfenbein
- , C O Freytes
- , R P Gale
- , M A Gertz
- , J Gibson
- , S A Giralt
- , A Keating
- , R A Kyle
- , D Maharaj
- , D Marcellus
- , P L McCarthy
- , G A Milone
- , S D Nimer
- , S Pavlovsky
- , L B To
- , D J Weisdorf
- , P H Wiernik
- , J R Wingard
- & D H Vesole
Bone Marrow Transplantation 32 , 1135–1143

Rights & permissionsfor article Autologous stem cell transplantation in multiple myeloma patients <60 <i>vs</i> <span class="stix">⩾</span>60 years of age . Opens in a new window.
8 April 2003
Thalidomide as initial therapy for early-stage myeloma
- S V Rajkumar
- , M A Gertz
- , M Q Lacy
- , A Dispenzieri
- , R Fonseca
- , S M Geyer
- , N Iturria
- , S Kumar
- , J A Lust
- , R A Kyle
- , P R Greipp
- & T E Witzig
Leukemia 17 , 775–779

Rights & permissionsfor article Thalidomide as initial therapy for early-stage myeloma . Opens in a new window.
18 February 2003
Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma
- C S Debes-Marun
- , G W Dewald
- , S Bryant
- , E Picken
- , R Santana-Dávila
- , N González-Paz
- , J M Winkler
- , R A Kyle
- , M A Gertz
- , T E Witzig
- , A Dispenzieri
- , M Q Lacy
- , S V Rajkumar
- , J A Lust
- , P R Greipp
- & R Fonseca
Leukemia 17 , 427–436

Rights & permissionsfor article Chromosome abnormalities clustering and its implications for pathogenesis and prognosis in myeloma . Opens in a new window.
5 June 2008
Clinical and biological significance of RAS mutations in multiple myeloma
- W J Chng
- , N Gonzalez-Paz
- , T Price-Troska
- , S Jacobus
- , S V Rajkumar
- , M M Oken
- , R A Kyle
- , K J Henderson
- , S Van Wier
- , P Greipp
- , B Van Ness
- & R Fonseca
Leukemia 22 , 2280–2284

Rights & permissionsfor article Clinical and biological significance of <i>RAS</i> mutations in multiple myeloma . Opens in a new window.

Quick links